NATCO Pharma Limited

NATCO Pharma Limitedverified

NATCOPHARM.BO

Price:

$917.9

Market Cap:

$164.20B

NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products f...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2001-03-02

Stock Exchange

BSE

Ticker

NATCOPHARM.BO

The PE Ratio as of December 2025 (TTM) for NATCO Pharma Limited (NATCOPHARM.BO) is 10.69

According to NATCO Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is 10.69. This represents a change of -39.82% compared to the average of 17.76 of the last 4 quarters.

NATCO Pharma Limited (NATCOPHARM.BO) Historical PE Ratio (quarterly & annually)

How has NATCOPHARM.BO PE Ratio performed in the past?

The mean historical PE Ratio of NATCO Pharma Limited over the last ten years is 28.19. The current 10.69 PE Ratio has changed 3.69% with respect to the historical average. Over the past ten years (40 quarters), NATCOPHARM.BO's PE Ratio was at its highest in in the March 2021 quarter at 71.17. The PE Ratio was at its lowest in in the March 2022 quarter at -68.24.

Quarterly (TTM)
Annual

Average

28.19

Median

19.86

Minimum

7.65

Maximum

81.13

NATCO Pharma Limited (NATCOPHARM.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NATCO Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 137.43%

Maximum Annual PE Ratio = 81.13

Minimum Annual Increase = -82.28%

Minimum Annual PE Ratio = 7.65

Quarterly (TTM)
Annual
YearPE RatioChange
20257.65-39.26%
202412.59-12.44%
202314.38-82.28%
202281.13137.43%
202134.1770.73%
202020.0123.48%
201916.21-17.78%
201819.71-35.30%
201730.47-33.11%
201645.55-15.69%

NATCO Pharma Limited (NATCOPHARM.BO) Average PE Ratio

How has NATCOPHARM.BO PE Ratio performed in the past?

The current PE Ratio of NATCO Pharma Limited (NATCOPHARM.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

11.54

5-year avg

29.98

10-year avg

28.19

NATCO Pharma Limited (NATCOPHARM.BO) PE Ratio vs. Peers

How is NATCOPHARM.BO’s PE Ratio compared to its peers?

NATCO Pharma Limited’s PE Ratio is less than Caplin Point Laboratories Limited (24.88), less than Granules India Limited (27.61), less than Granules India Limited (27.61), less than Jubilant Pharmova Limited (36.05), less than Jubilant Pharmova Limited (36.05), less than Alembic Pharmaceuticals Limited (26.64), less than Alembic Pharmaceuticals Limited (26.64), less than Concord Biotech Limited (43.20), less than Concord Biotech Limited (43.20), less than Rainbow Children's Medicare Limited (52.73),

Build a custom stock screener for NATCO Pharma Limited (NATCOPHARM.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NATCO Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NATCO Pharma Limited (NATCOPHARM.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NATCO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is NATCO Pharma Limited's PE Ratio?

How is the PE Ratio calculated for NATCO Pharma Limited (NATCOPHARM.BO)?

What is the highest PE Ratio for NATCO Pharma Limited (NATCOPHARM.BO)?

What is the 3-year average PE Ratio for NATCO Pharma Limited (NATCOPHARM.BO)?

What is the 5-year average PE Ratio for NATCO Pharma Limited (NATCOPHARM.BO)?

How does the current PE Ratio for NATCO Pharma Limited (NATCOPHARM.BO) compare to its historical average?